November/December 2014

Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions

March 02, 2015

The American Journal of Pharmacy Benefits

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.

Self-Reported Plan Switching in Medicare Part D: 2006-2010

March 02, 2015

The American Journal of Pharmacy Benefits

Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.

Improving Transitions of Care for Patients With Acute Coronary Syndromes: A Focus on the Role of the Health System and Community Pharmacists on Adherence

December 16, 2014

The American Journal of Pharmacy Benefits

The intended audience for this activity consists of medical directors, pharmacy directors, pharmacy benefit managers, and other managed care professionals who are involved with the treatment of patients with acute coronary syndrome.

Rheumatoid Arthritis and Joint Replacement: Impact of Biologics

December 16, 2014

The American Journal of Pharmacy Benefits

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.

Making the 2016 Marketplace More Patient Focused

December 16, 2014

The American Journal of Pharmacy Benefits

The time is now to develop a consensus on how patient needs, health plan sustainability, and government regulations intertwine to create a more patient-focused insurance marketplace.